BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharaiha RZ, Halazun KJ, Mirza F, Port JL, Lee PC, Neugut AI, Altorki NK, Abrams JA. Elevated preoperative neutrophil: lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol. 2011;18:3362-3369. [PMID: 21547702 DOI: 10.1245/s10434-011-1754-8] [Cited by in Crossref: 194] [Cited by in F6Publishing: 211] [Article Influence: 17.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Heng X, Luo Y, Li L, Zhang H, Che F, Li B. Negative lymph node at station 108 is a strong predictor of overall survival in esophageal cancer. Oncol Lett 2018;16:6705-12. [PMID: 30405812 DOI: 10.3892/ol.2018.9456] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Wan GX, Chen P, Cai XJ, Li LJ, Yu XJ, Pan DF, Wang XH, Wang XB, Cao FJ. Elevated red cell distribution width contributes to a poor prognosis in patients with esophageal carcinoma. Clin Chim Acta. 2016;452:199-203. [PMID: 26633854 DOI: 10.1016/j.cca.2015.11.025] [Cited by in Crossref: 20] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
3 Akinci Ozyurek B, Sahin Ozdemirel T, Buyukyaylaci Ozden S, Erdogan Y, Kaplan B, Kaplan T. Prognostic Value of the Neutrophil to Lymphocyte Ratio (NLR) in Lung Cancer Cases. Asian Pac J Cancer Prev. 2017;18:1417-1421. [PMID: 28612596 DOI: 10.22034/apjcp.2017.18.5.1417] [Cited by in F6Publishing: 26] [Reference Citation Analysis]
4 Wang Y, Liu JF. A retrospective study on the prognostic value of preoperative neutrophil/lymphocyte ratio in patients with primary small-cell carcinoma of the esophagus. Onco Targets Ther 2017;10:2453-9. [PMID: 28503068 DOI: 10.2147/OTT.S115637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
5 Ishibashi Y, Tsujimoto H, Kouzu K, Itazaki Y, Tsuchiya S, Fujishima S, Yaguchi Y, Sugasawa H, Nomura S, Ito N, Harada M, Nagata H, Shinto E, Kishi Y, Ueno H. Impact of Antiplatelet and Anticoagulant Therapies on Platelet-related Prognostic Markers in Patients With Esophageal Cancer. In Vivo 2020;34:1941-9. [PMID: 32606166 DOI: 10.21873/invivo.11991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Mitsuya K, Nakasu Y, Kurakane T, Hayashi N, Harada H, Nozaki K. Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of worse survival after resection in patients with brain metastasis. J Neurosurg 2017;127:433-7. [PMID: 27911233 DOI: 10.3171/2016.8.JNS16899] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
7 Jung J, Park SY, Park S, Park J. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma. Tumor Biol 2016;37:7149-54. [DOI: 10.1007/s13277-015-4596-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
8 Gao F, Sun L, Ye X, Liu Y, Liu H, Geng M, Li X, Yang X, Li Y, Wang R. Development and validation of a prognostic model for acute-on-chronic hepatitis B liver failure. Eur J Gastroenterol Hepatol. 2017;29:669-678. [PMID: 28195876 DOI: 10.1097/MEG.0000000000000854] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
9 Kargın S, Çakır M, Gündeş E, Yavuz Y, Esen HH, Sinan İyisoy M, Kökbudak N, Küçükkartallar T. Relationship of preoperative neutrophil lymphocyte ratio with prognosis in gastrointestinal stromal tumors. Ulus Cerrahi Derg 2015;31:61-4. [PMID: 26170750 DOI: 10.5152/UCD.2015.2840] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, Leibowitz-Amit R, Sonpavde G, Knox JJ, Tran B, Tannock IF, Amir E. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014;106:dju124. [PMID: 24875653 DOI: 10.1093/jnci/dju124] [Cited by in Crossref: 1177] [Cited by in F6Publishing: 1247] [Article Influence: 147.1] [Reference Citation Analysis]
11 Okadome K, Baba Y, Yagi T, Kiyozumi Y, Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N, Watanabe M, Baba H. Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients with Esophageal Cancer. Ann Surg 2020;271:693-700. [PMID: 30308614 DOI: 10.1097/SLA.0000000000002985] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 21.5] [Reference Citation Analysis]
12 Hoshino S, Takeuchi M, Kawakubo H, Kobayashi R, Matsuda S, Irino T, Fukuda K, Nakamura R, Kitagawa Y. Neutrophil-to-lymphocyte ratio change predicts histological response to and oncological outcome of neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Esophagus. [DOI: 10.1007/s10388-021-00901-6] [Reference Citation Analysis]
13 Kamarajah SK, Marson EJ, Zhou D, Wyn-Griffiths F, Lin A, Evans RPT, Bundred JR, Singh P, Griffiths EA. Meta-analysis of prognostic factors of overall survival in patients undergoing oesophagectomy for oesophageal cancer. Dis Esophagus 2020;33:doaa038. [PMID: 32448903 DOI: 10.1093/dote/doaa038] [Reference Citation Analysis]
14 Tustumi F, Takeda FR, Viyuela MS, da Cruz Junior JB, Brandão AAGS, Sallum RAA, Ribeiro Junior U, Cecconello I. The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer. J Surg Oncol 2020;121:784-94. [PMID: 31762058 DOI: 10.1002/jso.25778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Zhang Y, Brodin NP, Ohri N, Thibaud S, Kaubisch A, Kinkhabwala M, Garg M, Guha C, Kabarriti R. Association between neutrophil-lymphocyte ratio, socioeconomic status, and ethnic minority with treatment outcome in hepatocellular carcinoma. Hepatol Int 2019;13:609-17. [PMID: 31372942 DOI: 10.1007/s12072-019-09965-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
16 Zer A, Sung MR, Walia P, Khoja L, Maganti M, Labbe C, Shepherd FA, Bradbury PA, Feld R, Liu G, Iazzi M, Zawisza D, Nouriany N, Leighl NB. Correlation of Neutrophil to Lymphocyte Ratio and Absolute Neutrophil Count With Outcomes With PD-1 Axis Inhibitors in Patients With Advanced Non-Small-Cell Lung Cancer. Clin Lung Cancer 2018;19:426-434.e1. [PMID: 29803574 DOI: 10.1016/j.cllc.2018.04.008] [Cited by in Crossref: 48] [Cited by in F6Publishing: 55] [Article Influence: 12.0] [Reference Citation Analysis]
17 Feng JF, Chen S, Yang X. Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus. Medicine (Baltimore) 2017;96:e5886. [PMID: 28121932 DOI: 10.1097/MD.0000000000005886] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
18 Kelesoglu FM, Aygun E, Okumus NK, Ersoy A, Karapınar E, Saglam N, Aydın NG, Senay BB, Gonultas S, Sarisik E, Can MZ, Atay S, Basbug D, Tiryaki FK, Ozer S, Durmus RB, Orem F, Atay T, Acar A, Yilmaz Y, Kaya S, Ciftkaya A, Sarac Z, Makar CC, Saracoglu B, Dogdu G, Omeroglu RE. Evaluation of subclinical inflammation in familial Mediterranean fever patients: relations with mutation types and attack status: a retrospective study. Clin Rheumatol 2016;35:2757-63. [DOI: 10.1007/s10067-016-3275-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
19 Tham T, Bardash Y, Teegala S, Herman WS, Costantino PD. The red cell distribution width as a prognostic indicator in upper aerodigestive tract (UADT) cancer: A systematic review and meta-analysis. Am J Otolaryngol 2018;39:453-8. [PMID: 29699714 DOI: 10.1016/j.amjoto.2018.04.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
20 Feng JF, Huang Y, Liu JS. Combination of neutrophil lymphocyte ratio and platelet lymphocyte ratio is a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma. Onco Targets Ther. 2013;6:1605-1612. [PMID: 24403837 DOI: 10.2147/ott.s52501] [Cited by in Crossref: 11] [Cited by in F6Publishing: 39] [Article Influence: 1.2] [Reference Citation Analysis]
21 Wang J, Jia Y, Wang N, Zhang X, Tan B, Zhang G, Cheng Y. The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma. J Transl Med 2014;12:7. [PMID: 24397835 DOI: 10.1186/1479-5876-12-7] [Cited by in Crossref: 82] [Cited by in F6Publishing: 81] [Article Influence: 10.3] [Reference Citation Analysis]
22 Yu S, Wu D, Jin K, Yin L, Fu Y, Liu D, Zhang L, Yu X, Xu J. Low Serum Ionized Calcium, Elevated High-Sensitivity C-Reactive Protein, Neutrophil-Lymphocyte Ratio, and Body Mass Index (BMI) Are Risk Factors for Severe Acute Pancreatitis in Patients with Hypertriglyceridemia Pancreatitis. Med Sci Monit 2019;25:6097-103. [PMID: 31413252 DOI: 10.12659/MSM.915526] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
23 Yodying H, Matsuda A, Miyashita M, Matsumoto S, Sakurazawa N, Yamada M, Uchida E. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis. Ann Surg Oncol 2016;23:646-54. [DOI: 10.1245/s10434-015-4869-5] [Cited by in Crossref: 164] [Cited by in F6Publishing: 176] [Article Influence: 23.4] [Reference Citation Analysis]
24 Seretis C, Gourgiotis S, Gemenetzis G, Seretis F, Lagoudianakis E, Dimitrakopoulos G. The significance of neutrophil/lymphocyte ratio as a possible marker of underlying papillary microcarcinomas in thyroidal goiters: a pilot study. Am J Surg 2013;205:691-6. [PMID: 23388425 DOI: 10.1016/j.amjsurg.2012.08.006] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 6.2] [Reference Citation Analysis]
25 Duan H, Zhang X, Wang FX, Cai MY, Ma GW, Yang H, Fu JH, Tan ZH, Meng YQ, Fu XY, Ma QL, Lin P. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma. World J Gastroenterol 2015; 21(18): 5591-5597 [PMID: 25987784 DOI: 10.3748/wjg.v21.i18.5591] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
26 Takeda T, Takeuchi M, Saitoh M, Takeda S. Neutrophil-to-lymphocyte ratio after four weeks of nivolumab administration as a predictive marker in patients with pretreated non-small-cell lung cancer. Thorac Cancer 2018;9:1291-9. [PMID: 30126063 DOI: 10.1111/1759-7714.12838] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
27 Huang Y, Feng JF. Low preoperative lymphocyte to monocyte ratio predicts poor cancer-specific survival in patients with esophageal squamous cell carcinoma. Onco Targets Ther 2015;8:137-45. [PMID: 25609981 DOI: 10.2147/OTT.S73794] [Cited by in Crossref: 9] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
28 Li Y, Zou Z, Zhang Y, Zhu B, Ning Y, Shen B, Wang C, Luo Z, Xu J, Ding X. Dynamics in perioperative neutrophil-to-lymphocyte*platelet ratio as a predictor of early acute kidney injury following cardiovascular surgery. Ren Fail 2021;43:1012-9. [PMID: 34187280 DOI: 10.1080/0886022X.2021.1937220] [Reference Citation Analysis]
29 Moosazadeh M, Maleki I, Alizadeh-Navaei R, Kheradmand M, Hedayatizadeh-Omran A, Shamshirian A, Barzegar A. Normal values of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio among Iranian population: Results of Tabari cohort. Caspian J Intern Med 2019;10:320-5. [PMID: 31558995 DOI: 10.22088/cjim.10.3.320] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
30 Lin G, Liu Y, Li S, Mao Y, Wang J, Shuang Z, Chen J, Li S. Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma. Oncotarget 2016;7:50963-71. [PMID: 26918355 DOI: 10.18632/oncotarget.7680] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 9.0] [Reference Citation Analysis]
31 Arigami T, Uenosono Y, Matsushita D, Yanagita S, Uchikado Y, Kita Y, Mori S, Kijima Y, Okumura H, Maemura K. Combined fibrinogen concentration and neutrophil-lymphocyte ratio as a prognostic marker of gastric cancer. Oncol Lett. 2016;11:1537-1544. [PMID: 26893776 DOI: 10.3892/ol.2015.4049] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
32 Hou B, Wang P, Liu T, Chen S, Li T, Zhang S, Tao H, Li X, Hu Y. Association of the pretreatment lung immune prognostic index with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors. Clin Res Hepatol Gastroenterol 2021;45:101748. [PMID: 34182184 DOI: 10.1016/j.clinre.2021.101748] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Jagadesham VP, Lagarde SM, Immanuel A, Griffin SM. Systemic inflammatory markers and outcome in patients with locally advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction. British Journal of Surgery 2017;104:401-7. [DOI: 10.1002/bjs.10425] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
34 Fu SJ, Shen SL, Li SQ, Hua YP, Hu WJ, Liang LJ, Peng BG. Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy. Med Oncol. 2013;30:721. [PMID: 24026659 DOI: 10.1007/s12032-013-0721-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
35 Ishibashi Y, Tsujimoto H, Hiraki S, Kumano I, Yaguchi Y, Horiguchi H, Nomura S, Ito N, Shinto E, Aosasa S, Yamamoto J, Ueno H. Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with Esophageal Cancer. Ann Surg Oncol 2018;25:3288-99. [PMID: 30019304 DOI: 10.1245/s10434-018-6651-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
36 Mubder M, Dhindsa B, Nguyen D, Saghir S, Cross C, Makar R, Ohning G. Utility of inflammatory markers to predict adverse outcome in acute pancreatitis: A retrospective study in a single academic center. Saudi J Gastroenterol 2020. [PMID: 32719240 DOI: 10.4103/sjg.SJG_49_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
37 Pinato DJ, Mauri FA, Ramakrishnan R, Wahab L, Lloyd T, Sharma R. Inflammation-based prognostic indices in malignant pleural mesothelioma. J Thorac Oncol 2012;7:587-94. [PMID: 22307011 DOI: 10.1097/JTO.0b013e31823f45c1] [Cited by in Crossref: 82] [Cited by in F6Publishing: 50] [Article Influence: 8.2] [Reference Citation Analysis]
38 Chen TM, Lin CC, Huang PT, Wen CF. Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation. J Gastroenterol Hepatol. 2012;27:553-561. [PMID: 21913982 DOI: 10.1111/j.1440-1746.2011.06910.x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 104] [Article Influence: 9.9] [Reference Citation Analysis]
39 Zhang L, Wang R, Chen W, Xu X, Dong S, Fan H, Liu C. Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma. HPB (Oxford). 2016;18:600-607. [PMID: 27346141 DOI: 10.1016/j.hpb.2016.03.608] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
40 Nora I, Shridhar R, Huston J, Meredith K. The accuracy of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as a marker for gastrointestinal malignancies. J Gastrointest Oncol 2018;9:972-8. [PMID: 30505600 DOI: 10.21037/jgo.2018.08.05] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
41 Huang C, Yue J, Li Z, Li N, Zhao J, Qi D. Usefulness of the neutrophil-to-lymphocyte ratio in predicting lymph node metastasis in patients with non-small cell lung cancer. Tumour Biol 2015;36:7581-9. [PMID: 25921282 DOI: 10.1007/s13277-015-3462-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
42 Wang AH, Tan P, Zhuang Y, Zhang XT, Yu ZB, Li LN. Down-regulation of long non-coding RNA HOTAIR inhibits invasion and migration of oesophageal cancer cells via up-regulation of microRNA-204. J Cell Mol Med 2019;23:6595-610. [PMID: 31389660 DOI: 10.1111/jcmm.14502] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
43 Perisanidis C, Kornek G, Pöschl PW, Holzinger D, Pirklbauer K, Schopper C, Ewers R. High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer. Med Oncol 2013;30. [DOI: 10.1007/s12032-012-0334-5] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 7.3] [Reference Citation Analysis]
44 Jang JY, Yoo G, Lee T, Uh Y, Kim J. Identification of the robust predictor for sepsis based on clustering analysis. Sci Rep 2022;12:2336. [PMID: 35149759 DOI: 10.1038/s41598-022-06310-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 McShane R, Arya S, Stewart AJ, Caie P, Bates M. Prognostic features of the tumour microenvironment in oesophageal adenocarcinoma. Biochim Biophys Acta Rev Cancer 2021;:188598. [PMID: 34332022 DOI: 10.1016/j.bbcan.2021.188598] [Reference Citation Analysis]
46 Kosumi K, Baba Y, Ishimoto T, Harada K, Nakamura K, Ohuchi M, Kiyozumi Y, Izumi D, Tokunaga R, Taki K, Higashi T, Miyata T, Kurashige J, Hiyoshi Y, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Watanabe M, Baba H. Neutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patients. Surg Today 2016;46:405-13. [PMID: 26036223 DOI: 10.1007/s00595-015-1197-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
47 Lee SK, Lee SC, Park JW, Kim SJ. The utility of the preoperative neutrophil-to-lymphocyte ratio in predicting severe cholecystitis: a retrospective cohort study. BMC Surg 2014;14:100. [PMID: 25428640 DOI: 10.1186/1471-2482-14-100] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
48 Hsu BE, Shen Y, Siegel PM. Neutrophils: Orchestrators of the Malignant Phenotype. Front Immunol 2020;11:1778. [PMID: 32849639 DOI: 10.3389/fimmu.2020.01778] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
49 Ogura Y, Kataoka N, Kunimatsu Y, Tachibana Y, Sugimoto T, Tani N, Sato I, Hirose K, Kato D, Takeda T. Predictors of survival among Japanese patients receiving first-line chemoimmunotherapy for advanced non-small cell lung cancer. Thorac Cancer 2021;12:97-105. [PMID: 33124197 DOI: 10.1111/1759-7714.13720] [Reference Citation Analysis]
50 Li C, Lin JW, Yeh HL, Chuang CY, Chen CC. Good prediction of treatment responses to neoadjuvant chemoradiotherapy for esophageal cancer based on preoperative inflammatory status and tumor glucose metabolism. Sci Rep 2021;11:11626. [PMID: 34078965 DOI: 10.1038/s41598-021-90753-y] [Reference Citation Analysis]
51 Wang H, Ding Y, Li N, Wu L, Gao Y, Xiao C, Jiang H, Zheng Y, Mao C, Deng J, Wang H, Xu N. Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Combined Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Stage IV Advanced Gastric Cancer. Front Oncol 2020;10:841. [PMID: 32637353 DOI: 10.3389/fonc.2020.00841] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
52 Leman JKH, Munoz-Erazo L, Kemp RA. The Intestinal Tumour Microenvironment. Adv Exp Med Biol 2020;1226:1-22. [PMID: 32030672 DOI: 10.1007/978-3-030-36214-0_1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
53 Gao QF, Qiu JC, Huang XH, Xu YM, Li SQ, Sun F, Zhang J, Yang WM, Min QH, Jiang YH, Chen QG, Zhang L, Wang XZ, Ying HQ. The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy. Cancer Cell Int 2018;18:153. [PMID: 30305803 DOI: 10.1186/s12935-018-0648-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
54 Josse JM, Cleghorn MC, Ramji KM, Jiang H, Elnahas A, Jackson TD, Okrainec A, Quereshy FA. The neutrophil-to-lymphocyte ratio predicts major perioperative complications in patients undergoing colorectal surgery. Colorectal Dis 2016;18:O236-42. [DOI: 10.1111/codi.13373] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
55 Kim EJ, Kim JH, Song HJ, Park SR, Kim YH, Kim HR, Kim SB. Impact of sequential lines of palliative chemotherapy in patients with recurrent/metastatic esophageal squamous cell carcinoma: A retrospective analysis of 107 patients at a single center. Asia Pac J Clin Oncol 2020;16:e53-62. [PMID: 31657877 DOI: 10.1111/ajco.13283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Swierczak A, Mouchemore KA, Hamilton JA, Anderson RL. Neutrophils: important contributors to tumor progression and metastasis. Cancer Metastasis Rev 2015;34:735-51. [DOI: 10.1007/s10555-015-9594-9] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 11.9] [Reference Citation Analysis]
57 Wang GY, Yang Y, Li H, Zhang J, Jiang N, Li MR, Zhu HB, Zhang Q, Chen GH. A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation. PLoS One 2011;6:e25295. [PMID: 21966488 DOI: 10.1371/journal.pone.0025295] [Cited by in Crossref: 56] [Cited by in F6Publishing: 66] [Article Influence: 5.1] [Reference Citation Analysis]
58 Kuo MT, Hu TH, Lu SN, Hung CH, Wang JH, Chen CH, Chiu YC, Lee CM. Neutrophil-to-lymphocyte ratio as a predictor of response to peginterferon plus ribavirin therapy for chronic hepatitis C. Dis Markers 2014;2014:462958. [PMID: 25505815 DOI: 10.1155/2014/462958] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
59 Park JY, Kim YJ. Uncut Roux-en-Y Reconstruction after Laparoscopic Distal Gastrectomy Can Be a Favorable Method in Terms of Gastritis, Bile Reflux, and Gastric Residue. J Gastric Cancer. 2014;14:229-237. [PMID: 25580354 DOI: 10.5230/jgc.2014.14.4.229] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
60 Tho LM, Huh J, Sanders I, Carruthers R, Han S, McDonald A. Defining optimal cut-off values and research methodology for evaluating systemic inflammatory markers in clinical outcome prediction. World J Surg 2012;36:2742-3; author reply 2744-5. [PMID: 22717538 DOI: 10.1007/s00268-012-1685-y] [Reference Citation Analysis]
61 So YK, Lee G, Oh D, Byeon S, Park W, Chung MK. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with Human Papillomavirus-Positive Oropharyngeal Cancer. Otolaryngol Head Neck Surg 2018;159:303-9. [PMID: 29557259 DOI: 10.1177/0194599818764651] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
62 Ou Q, Cheng J, Zhang L, Wang H, Wang W, Ma Y. The prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer: Deleterious or advantageous? Tumour Biol 2017;39:1010428317706214. [PMID: 28653873 DOI: 10.1177/1010428317706214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
63 Koh CH, Bhoo-Pathy N, Ng KL, Jabir RS, Tan GH, See MH, Jamaris S, Taib NA. Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer. Br J Cancer 2015;113:150-8. [PMID: 26022929 DOI: 10.1038/bjc.2015.183] [Cited by in Crossref: 144] [Cited by in F6Publishing: 157] [Article Influence: 20.6] [Reference Citation Analysis]
64 Öztürk A, Şahan E, Mirçik AB, Deveci E, Yilmaz O, Kirpinar İ. Mean platelet volume and neutrophil to lymphocyte ratio decrease in patients with depression with antidepressant treatment. Arch Clin Psychiatry (São Paulo) 2019;46:9-13. [DOI: 10.1590/0101-60830000000184] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
65 Sürücü E, Demir Y, Şengöz T. The correlation between the metabolic tumor volume and hematological parameters in patients with esophageal cancer. Ann Nucl Med 2015;29:906-10. [PMID: 26296613 DOI: 10.1007/s12149-015-1020-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
66 Proctor MJ, McMillan DC, Morrison DS, Fletcher CD, Horgan PG, Clarke SJ. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer. 2012;107:695-699. [PMID: 22828611 DOI: 10.1038/bjc.2012.292] [Cited by in Crossref: 227] [Cited by in F6Publishing: 231] [Article Influence: 22.7] [Reference Citation Analysis]
67 Tustumi F, Takeda FR, Brandão AAGS, Sallum RAA, Ribeiro Junior U, Cecconello I. LYMPHOCYTE COUNT AND PLATELET VOLUME PREDICTS POSTOPERATIVE COMPLICATIONS IN ESOPHAGECTOMY FOR CANCER: A COHORT STUDY. Arq Gastroenterol 2019;56:377-85. [PMID: 31618397 DOI: 10.1590/S0004-2803.201900000-70] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
68 Haneda R, Hiramatsu Y, Kawata S, Honke J, Soneda W, Matsumoto T, Morita Y, Kikuchi H, Kamiya K, Takeuchi H. Survival impact of perioperative changes in prognostic nutritional index levels after esophagectomy. Esophagus 2021. [PMID: 34546503 DOI: 10.1007/s10388-021-00883-5] [Reference Citation Analysis]
69 Luo G, Guo M, Liu Z, Xiao Z, Jin K, Long J, Liu L, Liu C, Xu J, Ni Q, Yu X. Blood neutrophil-lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapy. Ann Surg Oncol. 2015;22:670-676. [PMID: 25155401 DOI: 10.1245/s10434-014-4021-y] [Cited by in Crossref: 86] [Cited by in F6Publishing: 94] [Article Influence: 10.8] [Reference Citation Analysis]
70 Feng JF, Huang Y, Chen QX. Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma. World J Surg Oncol 2014;12:58. [PMID: 24641770 DOI: 10.1186/1477-7819-12-58] [Cited by in Crossref: 125] [Cited by in F6Publishing: 139] [Article Influence: 15.6] [Reference Citation Analysis]
71 Xiao Q, Zhang B, Deng X, Wu J, Wang H, Wang Y, Wang W. The Preoperative Neutrophil-To-Lymphocyte Ratio Is a Novel Immune Parameter for the Prognosis of Esophageal Basaloid Squamous Cell Carcinoma. PLoS One 2016;11:e0168299. [PMID: 27959959 DOI: 10.1371/journal.pone.0168299] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
72 Gao HY, Zhang H, Xu XD, Zou WB, Lin KL, Deng YC, Liu QQ, Jiang JX, Wang M, Zhu F, Qin RY. Neutrophil-lymphocyte ratio as a prognostic factor for gallbladder carcinoma after radical resection. Shijie Huaren Xiaohua Zazhi 2015; 23(35): 5705-5710 [DOI: 10.11569/wcjd.v23.i35.5705] [Cited by in CrossRef: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 Kanatsios S, Melanoma Project M, Li Wai Suen CSN, Cebon JS, Gyorki DE. Neutrophil to lymphocyte ratio is an independent predictor of outcome for patients undergoing definitive resection for stage IV melanoma. J Surg Oncol 2018;118:915-21. [PMID: 30196539 DOI: 10.1002/jso.25138] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
74 Bowen RC, Little NAB, Harmer JR, Ma J, Mirabelli LG, Roller KD, Breivik AM, Signor E, Miller AB, Khong HT. Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis. Oncotarget 2017;8:32171-89. [PMID: 28418870 DOI: 10.18632/oncotarget.16291] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 9.3] [Reference Citation Analysis]
75 Arpaci AH, Işik B, Ilhan E, Erdem E. Association of Postoperative Nausea and Vomiting Incidence With Neutrophil-Lymphocyte Ratio in Ambulatory Maxillofacial Surgery. J Oral Maxillofac Surg 2017;75:1367-71. [PMID: 28137634 DOI: 10.1016/j.joms.2016.12.036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
76 Kim JY, Park T, Jeong SH, Jeong CY, Ju YT, Lee YJ, Hong SC, Ha WS, Choi SK, Jung EJ. Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas. Endocrine 2014;46:526-31. [PMID: 24272600 DOI: 10.1007/s12020-013-0089-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
77 Liu X, He L, Han J, Wang L, Li M, Jiang Y, Wang X, Yang Z. Association of neutrophil-lymphocyte ratio and T lymphocytes with the pathogenesis and progression of HBV-associated primary liver cancer. PLoS One. 2017;12:e0170605. [PMID: 28231294 DOI: 10.1371/journal.pone.0170605] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
78 Zhu GS, Tian SB, Wang H, Ma MG, Liu Y, Du HS, Long YP. Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Cannot Predict Lymph Node Metastasis and Prognosis in Patients with Early Gastric Cancer: a Single Institution Investigation in China. Curr Med Sci. 2018;38:78-84. [PMID: 30074155 DOI: 10.1007/s11596-018-1849-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
79 Zhang S, Tan Y, Cai X, Luo K, Wu Z, Lu J. Preoperative weight loss is associated with poorer prognosis in operable esophageal cancer patients: A single-center retrospective analysis of a large cohort of Chinese patients. J Cancer 2020;11:1994-9. [PMID: 32194811 DOI: 10.7150/jca.40344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Gupta P, Das GC, Bansal A, Samanta J, Mandavdhare HS, Sharma V, Naseem S, Gupta V, Yadav TD, Dutta U, Varma N, Sandhu MS, Kochhar R. Value of neutrophil-lymphocyte ratio in evaluating response to percutaneous catheter drainage in patients with acute pancreatitis. World J Clin Cases 2022; 10(1): 91-103 [DOI: 10.12998/wjcc.v10.i1.91] [Reference Citation Analysis]
81 Takeda T, Yamada T, Tanimura K, Nakano T, Ishida M, Tachibana Y, Shiotsu S, Horiuchi S, Hibino M, Okada A, Chihara Y, Takayama K. Prognostic Markers of Survival among Japanese Patients with Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer Receiving First-Line Alectinib. Diagnostics (Basel) 2021;11:2170. [PMID: 34943412 DOI: 10.3390/diagnostics11122170] [Reference Citation Analysis]
82 Hong C, Wei Y, Jiang J, Zhao C, Liang G, Wang G, Yang H. Associations between lifestyles and neutrophil-lymphocyte and platelet-lymphocyte ratios in colorectal cancer. Asia Pac J Clin Oncol. 2014;10:168-174. [PMID: 23714008 DOI: 10.1111/ajco.12080] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
83 Zhou XL, Li YQ, Zhu WG, Yu CH, Song YQ, Wang WW, He DC, Tao GZ, Tong YS. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. Sci Rep 2017;7:42581. [PMID: 28195186 DOI: 10.1038/srep42581] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
84 Nomoto D, Baba Y, Akiyama T, Okadome K, Iwatsuki M, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Baba H. Adapted systemic inflammation score as a novel prognostic marker for esophageal squamous cell carcinoma patients. Ann Gastroenterol Surg 2021;5:669-76. [PMID: 34585051 DOI: 10.1002/ags3.12464] [Reference Citation Analysis]
85 Hyder J, Boggs DH, Hanna A, Suntharalingam M, Chuong MD. Changes in neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios during chemoradiation predict for survival and pathologic complete response in trimodality esophageal cancer patients. J Gastrointest Oncol 2016;7:189-95. [PMID: 27034785 DOI: 10.3978/j.issn.2078-6891.2015.080] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
86 Ohira M, Yoshizumi T, Yugawa K, Kosai-Fujimoto Y, Inokuchi S, Motomura T, Mano Y, Toshima T, Itoh S, Harada N, Ikegami T, Soejima Y, Taketomi A, Mori M. Association of inflammatory biomarkers with long-term outcomes after curative surgery for mass-forming intrahepatic cholangiocarcinoma. Surg Today 2020;50:379-88. [PMID: 31667580 DOI: 10.1007/s00595-019-01905-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
87 Zhao Y, Zhao S, Chen Y, Dong X, Peng C, Sun Q, Shan L, Wang Z, Zhao X. Isolation of circulating tumor cells in patients undergoing surgery for esophageal cancer and a specific confirmation method. Oncol Lett 2019;17:3817-25. [PMID: 30881502 DOI: 10.3892/ol.2019.10017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
88 Dolan RD, Lim J, McSorley ST, Horgan PG, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis. Sci Rep. 2017;7:16717. [PMID: 29196718 DOI: 10.1038/s41598-017-16955-5] [Cited by in Crossref: 112] [Cited by in F6Publishing: 111] [Article Influence: 22.4] [Reference Citation Analysis]
89 Zhao Q, Chen S, Feng JF. A novel inflammation-based prognostic index for patients with esophageal squamous cell carcinoma: neutrophil lymphocyte ratio/albumin ratio. Oncotarget 2017;8:103535-42. [PMID: 29262582 DOI: 10.18632/oncotarget.21989] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
90 Shi L, Qu Z, Yang Y, Zhang Y, Sun D. Analysis of Related Risk Factors of Microvascular Invasion in Hepatocellular Carcinoma. Comput Math Methods Med 2022;2022:8195512. [PMID: 35356664 DOI: 10.1155/2022/8195512] [Reference Citation Analysis]
91 Wu CN, Chuang HC, Lin YT, Fang FM, Li SH, Chien CY. Prognosis of neutrophil-to-lymphocyte ratio in clinical early-stage tongue (cT1/T2N0) cancer. Onco Targets Ther 2017;10:3917-24. [PMID: 28831266 DOI: 10.2147/OTT.S140800] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
92 Liao G, Zhao Z, Yang H, Chen M, Li X. Can Prognostic Nutritional Index be a Prediction Factor in Esophageal Cancer?: A Meta-Analysis. Nutr Cancer 2020;72:187-93. [PMID: 31272238 DOI: 10.1080/01635581.2019.1631859] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
93 Chen K, Zhan MX, Hu BS, Li Y, He X, Fu SR, Xin YJ, Lu LG. Combination of the neutrophil to lymphocyte ratio and the platelet to lymphocyte ratio as a useful predictor for recurrence following radiofrequency ablation of hepatocellular carcinoma. Oncol Lett. 2018;15:315-323. [PMID: 29285194 DOI: 10.3892/ol.2017.7291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
94 Feng JF, Huang Y, Zhao Q, Chen QX. Clinical significance of preoperative neutrophil lymphocyte ratio versus platelet lymphocyte ratio in patients with small cell carcinoma of the esophagus. ScientificWorldJournal 2013;2013:504365. [PMID: 24089602 DOI: 10.1155/2013/504365] [Cited by in Crossref: 23] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
95 Kim JY, Park T, Jeong SH, Jeong CY, Ju YT, Lee YJ, Hong SC, Ha WS, Choi SK, Jung EJ. Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas. Endocrine 2014;46:526-31. [PMID: 24272600 DOI: 10.1007/s12020-013-0089-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
96 Nakamura K, Yoshida N, Baba Y, Kosumi K, Uchihara T, Kiyozumi Y, Ohuchi M, Ishimoto T, Iwatsuki M, Sakamoto Y, Watanabe M, Baba H. Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer. Int J Clin Oncol 2017;22:469-75. [PMID: 28097441 DOI: 10.1007/s10147-017-1090-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
97 Forget P, De Kock M. Perspectives in anaesthesia for cancer surgery. J Cancer Res Clin Oncol 2014;140:353-9. [PMID: 24077864 DOI: 10.1007/s00432-013-1522-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
98 Gong J, Liang Y, Zhou W, Jie Y, Xiao C, Chong Y, Hu B. Prognostic value of neutrophil-to-lymphocyte ratio associated with prognosis in HBV-infected patients. J Med Virol 2018;90:730-5. [DOI: 10.1002/jmv.25015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
99 Sionov RV. Leveling Up the Controversial Role of Neutrophils in Cancer: When the Complexity Becomes Entangled. Cells 2021;10:2486. [PMID: 34572138 DOI: 10.3390/cells10092486] [Reference Citation Analysis]
100 Mengxue Z, Ling G, Lili W, Ying L. Effect of scar-producing moxibustion at the acupoints Zusanli (ST 36) and Feishu (BL 13) on neutrophil-to-lymphocyte ratio and quality of life in patients with non-small-cell lung cancer: A randomized, controlled trial. Journal of Traditional Chinese Medicine 2018;38:439-46. [DOI: 10.1016/s0254-6272(18)30636-8] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
101 Sionov RV, Fridlender ZG, Granot Z. The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment. Cancer Microenviron. 2014; Jun 4. [Epub ahead of print]. [PMID: 24895166 DOI: 10.1007/s12307-014-0147-5] [Cited by in Crossref: 172] [Cited by in F6Publishing: 182] [Article Influence: 21.5] [Reference Citation Analysis]
102 Wan G, Gao F, Chen J, Li Y, Geng M, Sun L, Liu Y, Liu H, Yang X, Wang R. Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma. BMC Cancer. 2017;17:91. [PMID: 28143427 DOI: 10.1186/s12885-017-3062-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
103 Mouchli M, Reddy S, Gerrard M, Boardman L, Rubio M. Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review article. Ann Hepatol 2021;22:100249. [PMID: 32896610 DOI: 10.1016/j.aohep.2020.08.067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
104 Feng JF, Huang Y, Chen QX. A new inflammation index is useful for patients with esophageal squamous cell carcinoma. Onco Targets Ther 2014;7:1811-5. [PMID: 25336972 DOI: 10.2147/OTT.S68084] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
105 Yuan D, Zhu K, Li K, Yan R, Jia Y, Dang C. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction. J Surg Oncol 2014;110:333-40. [PMID: 24889121 DOI: 10.1002/jso.23651] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
106 Ishibashi Y, Tsujimoto H, Yaguchi Y, Kishi Y, Ueno H. Prognostic significance of systemic inflammatory markers in esophageal cancer: Systematic review and meta-analysis. Ann Gastroenterol Surg 2020;4:56-63. [PMID: 32021959 DOI: 10.1002/ags3.12294] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
107 Suppiah A, Malde D, Arab T, Hamed M, Allgar V, Smith AM, Morris-Stiff G. The prognostic value of the neutrophil-lymphocyte ratio (NLR) in acute pancreatitis: identification of an optimal NLR. J Gastrointest Surg. 2013;17:675-681. [PMID: 23371356 DOI: 10.1007/s11605-012-2121-1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
108 Wang W, Chen Y, Zhang X, Xi K, Feng X, Zhang L. A Model Shows Utility in Predicting Postoperative Recurrence and Distant Metastasis in Curatively Resected Esophageal Squamous Cell Cancer. Cancer Control 2019;26:1073274819852965. [PMID: 31146546 DOI: 10.1177/1073274819852965] [Reference Citation Analysis]
109 Wang H, Zhao J, Zhang M, Han L, Wang M, Xingde L. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer. J Cell Physiol 2018;233:4216-24. [PMID: 29057536 DOI: 10.1002/jcp.26239] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
110 Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88:218-230. [PMID: 23602134 DOI: 10.1016/j.critrevonc.2013.03.010] [Cited by in Crossref: 645] [Cited by in F6Publishing: 661] [Article Influence: 71.7] [Reference Citation Analysis]
111 Bugada D, Allegri M, Lavand'homme P, De Kock M, Fanelli G. Inflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patients. Biomed Res Int 2014;2014:142425. [PMID: 24877056 DOI: 10.1155/2014/142425] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
112 Tong YS, Tan J, Zhou XL, Song YQ, Song YJ. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer. J Transl Med 2017;15:221. [PMID: 29089030 DOI: 10.1186/s12967-017-1326-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 75] [Article Influence: 11.2] [Reference Citation Analysis]
113 Ji WH, Jiang YH, Ji YL, Li B, Mao WM. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy. Dis Esophagus 2016;29:403-11. [PMID: 25625421 DOI: 10.1111/dote.12322] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
114 Wu CC, Li SH, Lu HI, Lo CM, Wang YM, Chou SY, Chen YH. Inflammation-based prognostic scores predict the prognosis of locally advanced cervical esophageal squamous cell carcinoma patients receiving curative concurrent chemoradiotherapy: a propensity score-matched analysis. PeerJ 2018;6:e5655. [PMID: 30258731 DOI: 10.7717/peerj.5655] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
115 Zhou D, Zhang Y, Xu L, Zhou Z, Huang J, Chen M. A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma. Sci Rep. 2015;5:15263. [PMID: 26486016 DOI: 10.1038/srep15263] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
116 Wang B, Jiang XW, Tian DL, Zhou N, Geng W. Combination of Haemoglobin and Prognostic Nutritional Index Predicts the Prognosis of Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2020;12:8589-97. [PMID: 32982451 DOI: 10.2147/CMAR.S266821] [Reference Citation Analysis]
117 Tu XP, Qiu QH, Chen LS, Luo XN, Lu ZM, Zhang SY, Chen SH. Preoperative neutrophil-to-lymphocyte ratio is an independent prognostic marker in patients with laryngeal squamous cell carcinoma. BMC Cancer 2015;15:743. [PMID: 26482899 DOI: 10.1186/s12885-015-1727-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 4.7] [Reference Citation Analysis]
118 Yang W, Shou C, Yu J, Wang X, Zhang Q, Yu H, Lin X. Elevated preoperative controlling nutritional status (CONUT) scores as a predictor of postoperative recurrence in gastrointestinal stromal tumors. J Surg Oncol 2022. [PMID: 35912441 DOI: 10.1002/jso.27042] [Reference Citation Analysis]
119 Rahouma M, Aziz H, Ghaly G, Kamel M, Loai I, Mohamed A. Survival in Good Performance Malignant Pleural Mesothelioma Patients; Prognostic Factors and Predictors of Response. Asian Pac J Cancer Prev 2017;18:2073-8. [PMID: 28843224 DOI: 10.22034/APJCP.2017.18.8.2073] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Zhang JW, Huang L, Xu AM. Preoperative monocyte-lymphocyte and neutrophil-lymphocyte but not platelet-lymphocyte ratios are predictive of clinical outcomes in resected patients with non-metastatic Siewert type II/III adenocarcinoma of esophagogastric junction: a prospective cohort study (the AMONP corhort). Oncotarget 2017;8:57516-27. [PMID: 28915691 DOI: 10.18632/oncotarget.15497] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
121 Mahalakshmi R, Boaz K, Srikant N, Baliga M, Shetty P, Prasad M, Yellapurkar S, Lewis AJ. Neutrophil-to-lymphocyte Ratio: A Surrogate Marker for Prognosis of Oral Squamous Cell Carcinoma. Indian Journal of Medical and Paediatric Oncology 2021;39:8-12. [DOI: 10.4103/ijmpo.ijmpo_2_16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
122 Kim YH, Choi WJ. The effectiveness of postoperative neutrophils to lymphocytes ratio in predicting long-term recurrence after stomach cancer surgery. J Korean Surg Soc 2012;83:352-9. [PMID: 23230553 DOI: 10.4174/jkss.2012.83.6.352] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
123 Huang Y, Sun Y, Peng P, Zhu S, Sun W, Zhang P. Prognostic and clinicopathologic significance of neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma: evidence from a meta-analysis. Onco Targets Ther 2017;10:1165-72. [PMID: 28260931 DOI: 10.2147/OTT.S126637] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
124 Gong J, Zhou W, Xiao C, Jie Y, Zhu S, Zheng J, Chong Y, Hu B. A nomogram for predicting prognostic value of inflammatory biomarkers in patients with acute-on-chronic liver failure. Clin Chim Acta 2018;478:7-12. [PMID: 29247632 DOI: 10.1016/j.cca.2017.12.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
125 Ruan DY, Lin ZX, Li Y, Jiang N, Li X, Wu DH, Wang TT, Chen J, Lin Q, Wu XY. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy. World J Gastroenterol 2015; 21(18): 5598-5606 [PMID: 25987785 DOI: 10.3748/wjg.v21.i18.5598] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
126 Paramanathan A, Saxena A, Morris DL. A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours. Surgical Oncology 2014;23:31-9. [DOI: 10.1016/j.suronc.2013.12.001] [Cited by in Crossref: 176] [Cited by in F6Publishing: 183] [Article Influence: 22.0] [Reference Citation Analysis]
127 Miao C, Zhu S, Pan H, Cao X, Yuan S, Hu X. Combined neutrophil-platelet score and hemoglobin level predict survival in esophageal squamous cell carcinoma patients treated with chemoradiotherapy. Oncotarget 2017;8:87971-9. [PMID: 29152134 DOI: 10.18632/oncotarget.21313] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
128 Malleo G, Tonsi A, Marchegiani G, Casarotto A, Paiella S, Butturini G, Salvia R, Bassi C. Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma. Langenbecks Arch Surg. 2013;398:287-294. [PMID: 22801737 DOI: 10.1007/s00423-012-0978-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
129 Cannon NA, Meyer J, Iyengar P, Ahn C, Westover KD, Choy H, Timmerman R. Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios as Prognostic Factors after Stereotactic Radiation Therapy for Early-Stage Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology 2015;10:280-5. [DOI: 10.1097/jto.0000000000000399] [Cited by in Crossref: 88] [Cited by in F6Publishing: 70] [Article Influence: 12.6] [Reference Citation Analysis]
130 Xie X, Luo K, Hu Y, Wang J, Chen J. Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer: Preoperative PLR and ESCC outcomes. Dis Esophagus 2016;29:79-85. [DOI: 10.1111/dote.12296] [Cited by in Crossref: 40] [Cited by in F6Publishing: 55] [Article Influence: 5.0] [Reference Citation Analysis]
131 Forget P, Bentin C, Machiels JP, Berliere M, Coulie PG, De Kock M. Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery. Br J Anaesth 2014;113 Suppl 1:i82-7. [PMID: 24464611 DOI: 10.1093/bja/aet464] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 9.5] [Reference Citation Analysis]
132 Noble F, Hopkins J, Curtis N, Kelly JJ, Bailey IS, Byrne JP, Bateman AC, Bateman AR, Underwood TJ. The role of systemic inflammatory and nutritional blood-borne markers in predicting response to neoadjuvant chemotherapy and survival in oesophagogastric cancer. Med Oncol. 2013;30:596. [PMID: 23690267 DOI: 10.1007/s12032-013-0596-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
133 Minkov P, Gulubova M, Chilingirov P, Ananiev J. The Position of Neutrophils-To-Lymphocytes and Lymphocytes-To-Platelets Ratio as Predictive Markers of Progression and Prognosis in Patients with Non-Small Cell Lung Cancer. Open Access Maced J Med Sci 2018;6:1382-6. [PMID: 30159061 DOI: 10.3889/oamjms.2018.210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
134 Toyokawa T, Kubo N, Tamura T, Sakurai K, Amano R, Tanaka H, Muguruma K, Yashiro M, Hirakawa K, Ohira M. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study. BMC Cancer 2016;16:722. [PMID: 27599460 DOI: 10.1186/s12885-016-2696-0] [Cited by in Crossref: 83] [Cited by in F6Publishing: 93] [Article Influence: 13.8] [Reference Citation Analysis]
135 Xu W, Yang M, Zhao C, Wang P, Deng K, Yang X, Wei H, Xiao J. Massive Spondylectomy for Metastatic Spinal Cord Compression From Non-Small-Cell Lung Cancer With Local Failure After Radiotherapy. Global Spine J 2021;11:549-55. [PMID: 32875923 DOI: 10.1177/2192568220919099] [Reference Citation Analysis]
136 Cescon M, Bertuzzo VR, Ercolani G, Ravaioli M, Odaldi F, Pinna AD. Liver transplantation for hepatocellular carcinoma: Role of inflammatory and immunological state on recurrence and prognosis. World J Gastroenterol 2013; 19(48): 9174-9182 [PMID: 24409045 DOI: 10.3748/wjg.v19.i48.9174] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
137 Liu R, Zheng S, Yuan Q, Zhu P, Li B, Lin Q, Shi W, Min Y, Ge Q, Shao Y. The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis. Dis Markers 2020;2020:4565379. [PMID: 33376559 DOI: 10.1155/2020/4565379] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
138 Celikbilek M, Dogan S, Akyol L, Borekci E, Zararsiz G, Kozan M, Gunaydin I. Neutrophil-lymphocyte ratio in patients with familial Mediterranean fever. J Clin Lab Anal 2015;29:80-3. [PMID: 24687426 DOI: 10.1002/jcla.21732] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
139 Buonaguro L, Tagliamonte M, Petrizzo A, Damiano E, Tornesello ML, Buonaguro FM. Cellular prognostic markers in hepatocellular carcinoma. Future Oncol 2015;11:1591-8. [PMID: 26043213 DOI: 10.2217/fon.15.39] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
140 Feng JF, Huang Y, Chen QX. The combination of platelet count and neutrophil lymphocyte ratio is a predictive factor in patients with esophageal squamous cell carcinoma. Transl Oncol 2014;7:632-7. [PMID: 25389458 DOI: 10.1016/j.tranon.2014.07.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
141 Shen S, Araujo JL, Altorki NK, Sonett JR, Rodriguez A, Sungur-Stasik K, Spinelli CF, Neugut AI, Abrams JA. Variation by stage in the effects of prediagnosis weight loss on mortality in a prospective cohort of esophageal cancer patients. Dis Esophagus 2017;30:1-7. [PMID: 28859366 DOI: 10.1093/dote/dox073] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
142 Cheong TY, Hong SD, Jung KW, So YK. The diagnostic predictive value of neutrophil-to-lymphocyte ratio in thyroid cancer adjusted for tumor size. PLoS One 2021;16:e0251446. [PMID: 33974674 DOI: 10.1371/journal.pone.0251446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Sullivan KM, Groeschl RT, Turaga KK, Tsai S, Christians KK, White SB, Rilling WS, Pilgrim CH, Gamblin TC. Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: a Western perspective. J Surg Oncol. 2014;109:95-97. [PMID: 24122764 DOI: 10.1002/jso.23448] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
144 Koh YW, Kang HJ, Park C, Yoon DH, Kim S, Suh C, Kim JE, Kim CW, Huh J. Prognostic significance of the ratio of absolute neutrophil count to absolute lymphocyte count in classic Hodgkin lymphoma. Am J Clin Pathol 2012;138:846-54. [PMID: 23161719 DOI: 10.1309/AJCPO46GFKGNXCBR] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
145 Sugiura T, Uesaka K, Kanemoto H, Mizuno T, Okamura Y. Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after gastroenterostomy in patients with advanced pancreatic adenocarcinoma. Ann Surg Oncol. 2013;20:4330-4337. [PMID: 23982254 DOI: 10.1245/s10434-013-3227-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
146 Yang X, Huang Y, Feng JF, Liu JS. Prognostic significance of neutrophil-to- lymphocyte ratio in esophageal cancer: a meta-analysis. Onco Targets Ther 2015;8:789-94. [PMID: 25914549 DOI: 10.2147/OTT.S77099] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
147 Zhang X, Jiang Y, Wang Y, Wang Z, Zhao L, Xue X, Sang S, Zhang L. Prognostic role of neutrophil-lymphocyte ratio in esophageal cancer: A systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e13585. [PMID: 30544482 DOI: 10.1097/MD.0000000000013585] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
148 Yang HJ, Guo Z, Yang YT, Jiang JH, Qi YP, Li JJ, Li LQ, Xiang BD. Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis. World J Gastroenterol 2016; 22(21): 5088-5095 [PMID: 27275101 DOI: 10.3748/wjg.v22.i21.5088] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
149 Oba T, Maeno K, Takekoshi D, Ono M, Ito T, Kanai T, Ito KI. Neoadjuvant chemotherapy-induced decrease of prognostic nutrition index predicts poor prognosis in patients with breast cancer. BMC Cancer 2020;20:160. [PMID: 32106833 DOI: 10.1186/s12885-020-6647-4] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
150 Mallappa S, Sinha A, Gupta S, Chadwick SJ. Preoperative neutrophil to lymphocyte ratio & gt; 5 is a prognostic factor for recurrent colorectal cancer. Colorectal Dis. 2013;15:323-328. [PMID: 22958479 DOI: 10.1111/codi.12008] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 9.4] [Reference Citation Analysis]
151 Yang J, Gu Y, Huang X, Xu J, Zhang Y, Yang X, Tian H, Zhan W. Prognostic impact of preoperative neutrophil-lymphocyte ratio for surgically resected gastrointestinal stromal tumors. Medicine (Baltimore) 2019;98:e15319. [PMID: 31008985 DOI: 10.1097/MD.0000000000015319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
152 Forget P, Berlière M, van Maanen A, Duhoux FP, Machiels JP, Coulie PG, Bouche G, De Kock M; Ketorolac in Breast Cancer trial (KBCtrial) group. Perioperative ketorolac in high risk breast cancer patients. Rationale, feasibility and methodology of a prospective randomized placebo-controlled trial. Med Hypotheses 2013;81:707-12. [PMID: 23937996 DOI: 10.1016/j.mehy.2013.07.033] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
153 Wang Y, Liu P, Xu Y, Zhang W, Tong L, Guo Z, Ni H. Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer. Cancer Chemother Pharmacol 2015;75:255-62. [DOI: 10.1007/s00280-014-2622-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
154 Sato S, Kunisaki C, Suematsu H, Tanaka Y, Miyamoto H, Kosaka T, Yukawa N, Tanaka K, Sato K, Akiyama H, Endo I. Impact of Sarcopenia in Patients with Unresectable Locally Advanced Esophageal Cancer Receiving Chemoradiotherapy. In Vivo 2018;32:603-10. [PMID: 29695567 DOI: 10.21873/invivo.11282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
155 Nayak A, McDowell DT, Kellie SJ, Karpelowsky J. Elevated Preoperative Neutrophil-Lymphocyte Ratio is Predictive of a Poorer Prognosis for Pediatric Patients with Solid Tumors. Ann Surg Oncol 2017;24:3456-62. [PMID: 28718035 DOI: 10.1245/s10434-017-6006-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
156 Pirozzolo G, Gisbertz SS, Castoro C, van Berge Henegouwen MI, Scarpa M. Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer: a systematic review and meta-analysis. J Thorac Dis 2019;11:3136-45. [PMID: 31463142 DOI: 10.21037/jtd.2019.07.30] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
157 Rosenblatt RE, Tafesh ZH, Halazun KJ. Role of inflammatory markers as hepatocellular cancer selection tool in the setting of liver transplantation. Transl Gastroenterol Hepatol 2017;2:95. [PMID: 29264433 DOI: 10.21037/tgh.2017.10.04] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
158 Ishibashi Y, Tsujimoto H. ASO Author Reflections: Immunoinflammatory Prognostics in Cancer. Ann Surg Oncol 2018;25:731-2. [PMID: 30298326 DOI: 10.1245/s10434-018-6870-2] [Reference Citation Analysis]
159 Trevisani LFM, Kulcsar IF, Leite AKN, Kulcsar MAV, Lima GAS, Dedivitis RA, Kowalski LP, Matos LLD. Nutritional and immunological parameters as prognostic factors in patients with advanced oral cancer. Brazilian Journal of Otorhinolaryngology 2021. [DOI: 10.1016/j.bjorl.2021.11.003] [Reference Citation Analysis]
160 Jeon TJ, Park JY. Clinical significance of the neutrophil-lymphocyte ratio as an early predictive marker for adverse outcomes in patients with acute pancreatitis. World J Gastroenterol 2017; 23(21): 3883-3889 [PMID: 28638228 DOI: 10.3748/wjg.v23.i21.3883] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
161 Li B, Xiong F, Yi S, Wang S. Prognostic and Clinicopathologic Significance of Neutrophil-to-Lymphocyte Ratio in Esophageal Cancer: An Update Meta-Analysis. Technol Cancer Res Treat 2022;21:15330338211070140. [PMID: 35025614 DOI: 10.1177/15330338211070140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
162 Rimando J, Campbell J, Kim JH, Tang SC, Kim S. The Pretreatment Neutrophil/Lymphocyte Ratio Is Associated with All-Cause Mortality in Black and White Patients with Non-metastatic Breast Cancer. Front Oncol 2016;6:81. [PMID: 27064712 DOI: 10.3389/fonc.2016.00081] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
163 Laszkowska M, Tramontano AC, Kim J, Camargo MC, Neugut AI, Abrams JA, Hur C. Racial and ethnic disparities in mortality from gastric and esophageal adenocarcinoma. Cancer Med 2020;9:5678-86. [PMID: 32573964 DOI: 10.1002/cam4.3063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
164 Wang L, Lin Y, Long H, Liu H, Rao H, He Y, Rong T, Liang Y. Esophageal carcinosarcoma: a unique entity with better prognosis. Ann Surg Oncol. 2013;20:997-1004. [PMID: 23010734 DOI: 10.1245/s10434-012-2658-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
165 Lee BS, Lee SH, Son JH, Jang DK, Chung KH, Lee YS, Paik WH, Ryu JK, Kim YT. Neutrophil-lymphocyte ratio predicts survival in patients with advanced cholangiocarcinoma on chemotherapy. Cancer Immunol Immunother 2016;65:141-50. [PMID: 26728479 DOI: 10.1007/s00262-015-1780-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
166 Yoo EJ, Park JC, Kim EH, Park CH, Shim CN, Lee HJ, Chung HS, Lee H, Shin SK, Lee SK, Lee CG, Lee YC. Prognostic value of neutrophil-to-lymphocyte ratio in patients treated with concurrent chemoradiotherapy for locally advanced oesophageal cancer. Digestive and Liver Disease 2014;46:846-53. [DOI: 10.1016/j.dld.2014.05.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
167 Wang X, Teng F, Kong L, Yu J. Pretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancer. Onco Targets Ther 2016;9:5761-70. [PMID: 27703374 DOI: 10.2147/OTT.S106296] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
168 Russu E, Mureșan AV, Arbănași EM, Kaller R, Hosu I, Voidăzan S, Arbănași EM, Coșarcă CM. The Predictive Role of NLR and PLR in Outcome and Patency of Lower Limb Revascularization in Patients with Femoropopliteal Disease. JCM 2022;11:2620. [DOI: 10.3390/jcm11092620] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
169 Xue W, Zhang X, Niu Z, Xin Z, Zhang H, Zhao Q, He J, Hu Z, Duan G. Neutrophil-Lymphocyte Ratio as a Predictive Factor of Growing Malignant Pulmonary Ground-glass Opacity. Cancer Manag Res 2021;13:5651-5. [PMID: 34285585 DOI: 10.2147/CMAR.S319190] [Reference Citation Analysis]
170 Chen N, Liu S, Huang L, Li W, Yang W, Cong T, Ding L, Qiu M. Prognostic significance of neutrophil-to-lymphocyte ratio in patients with malignant pleural mesothelioma: a meta-analysis. Oncotarget 2017;8:57460-9. [PMID: 28915685 DOI: 10.18632/oncotarget.15404] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
171 Donskov F. Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin Cancer Biol. 2013;23:200-207. [PMID: 23403174 DOI: 10.1016/j.semcancer.2013.02.001] [Cited by in Crossref: 166] [Cited by in F6Publishing: 169] [Article Influence: 18.4] [Reference Citation Analysis]
172 Aires FT, Dedivitis RA, Kulcsar MAV, Ramos DM, Cernea CR. Neutrophil-to-lymphocyte ratio as a prognostic factor for pharyngocutaneous fistula after total laryngectomy. Acta Otorhinolaryngol Ital 2018;38:31-7. [PMID: 29756613 DOI: 10.14639/0392-100X-1572] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
173 Tang H, Lu W, Li B, Li C, Xu Y, Dong J. Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysis. Oncotarget 2017;8:36857-68. [PMID: 28415734 DOI: 10.18632/oncotarget.16143] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
174 Pourafkari L, Wang CK, Tajlil A, Afshar AH, Schwartz M, Nader ND. platelet-lymphocyte ratio in prediction of outcome of acute heart failure. Biomark Med 2018;12:63-70. [PMID: 29172672 DOI: 10.2217/bmm-2017-0193] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
175 Sakin A, Alay M, Sahin S, Aydemir O, Aldemir MN, Sakin A, Kotan C. Prognostic significance of neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma. North Clin Istanb 2021;8:435-42. [PMID: 34909581 DOI: 10.14744/nci.2020.63004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Davis JL, Langan RC, Panageas KS, Zheng J, Postow MA, Brady MS, Ariyan C, Coit DG. Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma. Ann Surg Oncol 2017;24:1989-96. [PMID: 28303429 DOI: 10.1245/s10434-017-5836-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
177 Magalhaes MAO, Glogauer JE, Glogauer M. Neutrophils and oral squamous cell carcinoma: lessons learned and future directions. Journal of Leukocyte Biology 2014;96:695-702. [DOI: 10.1189/jlb.4ru0614-294r] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
178 Hu J, Chen D, Wu S, Chen Y, Li R, Miao H, Wen Z. Prognostic significance of neutrophil-to-lymphocyte ratio in middle thoracic esophageal squamous cell carcinoma patients undergoing radical esophagectomy. J Thorac Dis 2020;12:363-74. [PMID: 32274102 DOI: 10.21037/jtd.2020.01.31] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
179 Messager M, Neofytou K, Chaudry MA, Allum WH. Prognostic impact of preoperative platelets to lymphocytes ratio (PLR) on survival for oesophageal and junctional carcinoma treated with neoadjuvant chemotherapy: A retrospective monocentric study on 153 patients. Eur J Surg Oncol 2015;41:1316-23. [PMID: 26166786 DOI: 10.1016/j.ejso.2015.06.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
180 He YF, Luo HQ, Wang W, Chen J, Yao YW, Yan Y, Wu SS, Hu XX, Ke LH, Niu JY, Li HM, Ji CS, Hu B. Preoperative NLR and PLR in the middle or lower ESCC patients with radical operation. Eur J Cancer Care (Engl) 2017;26. [PMID: 26947428 DOI: 10.1111/ecc.12445] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
181 Chen J, Deng Q, Pan Y, He B, Ying H, Sun H, Liu X, Wang S. Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer. FEBS Open Bio 2015;5:502-7. [PMID: 26137435 DOI: 10.1016/j.fob.2015.05.003] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 7.6] [Reference Citation Analysis]
182 Kubo N, Ohira M, Tamura T, Sakurai K, Toyokawa T, Tanaka H, Yashiro M, Yamashita Y, Hirakawa K. Prognostic significance of baseline nutritional index for patients with esophageal squamous cell carcinoma after radical esophagectomy. Esophagus 2017;14:84-90. [DOI: 10.1007/s10388-016-0548-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
183 Horvathova L, Tillinger A, Sivakova I, Mikova L, Mravec B, Bucova M. Chemical sympathectomy increases neutrophil-to-lymphocyte ratio in tumor-bearing rats but does not influence cancer progression. J Neuroimmunol 2015;278:255-61. [PMID: 25468774 DOI: 10.1016/j.jneuroim.2014.11.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
184 Sun P, Chen C, Zhang F, Yang H, Bi XW, An X, Wang FH, Jiang WQ. Combined heavy smoking and drinking predicts overall but not disease-free survival after curative resection of locoregional esophageal squamous cell carcinoma. Onco Targets Ther 2016;9:4257-64. [PMID: 27471400 DOI: 10.2147/OTT.S104182] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
185 Luo X, Yu B, Jiang N, Du Q, Ye X, Li H, Wang WQ, Zhai Q. Chemotherapy-Induced Reduction of Neutrophil-to-Lymphocyte Ratio Is Associated With Better Survival in Pancreatic Adenocarcinoma: A Meta-Analysis. Cancer Control 2020;27:1073274820977135. [PMID: 33269614 DOI: 10.1177/1073274820977135] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Rakic A, Beaudry P, Mahoney DJ. The complex interplay between neutrophils and cancer. Cell Tissue Res 2018;371:517-29. [DOI: 10.1007/s00441-017-2777-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
187 Jaillon S, Ponzetta A, Di Mitri D, Santoni A, Bonecchi R, Mantovani A. Neutrophil diversity and plasticity in tumour progression and therapy. Nat Rev Cancer 2020;20:485-503. [PMID: 32694624 DOI: 10.1038/s41568-020-0281-y] [Cited by in Crossref: 83] [Cited by in F6Publishing: 94] [Article Influence: 41.5] [Reference Citation Analysis]
188 Chen PC, Feng JF. A Novel Inflammation-Based Stage (I Stage) in Patients with Resectable Esophageal Squamous Cell Carcinoma. Mediators Inflamm 2016;2016:5396747. [PMID: 27212808 DOI: 10.1155/2016/5396747] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
189 Forget P, Machiels JP, Coulie PG, Berliere M, Poncelet AJ, Tombal B, Stainier A, Legrand C, Canon JL, Kremer Y, De Kock M. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery. Ann Surg Oncol 2013;20 Suppl 3:S650-60. [PMID: 23884751 DOI: 10.1245/s10434-013-3136-x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 87] [Article Influence: 9.4] [Reference Citation Analysis]
190 Wang C, Zhao K, Hu S, Huang Y, Ma L, Song Y, Li M. A predictive model for treatment response in patients with locally advanced esophageal squamous cell carcinoma after concurrent chemoradiotherapy: based on SUVmean and NLR. BMC Cancer 2020;20:544. [PMID: 32522277 DOI: 10.1186/s12885-020-07040-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
191 Yao Y, Yuan D, Liu H, Gu X, Song Y. Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy. Cancer Immunol Immunother. 2013;62:471-479. [PMID: 22986452 DOI: 10.1007/s00262-012-1347-9] [Cited by in Crossref: 95] [Cited by in F6Publishing: 107] [Article Influence: 9.5] [Reference Citation Analysis]
192 Forget P, Khalifa C, Defour JP, Latinne D, Van Pel MC, De Kock M. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes 2017;10:12. [PMID: 28057051 DOI: 10.1186/s13104-016-2335-5] [Cited by in Crossref: 178] [Cited by in F6Publishing: 166] [Article Influence: 35.6] [Reference Citation Analysis]
193 Xue A, Gao X, Fang Y, Shu P, Ling J, Shen K, Sun Y, Qin J, Qin X, Hou Y. Incorporation of NLR into NIH stratification system increases predictive accuracy for surgically resected gastrointestinal stromal tumors. Acta Biochim Biophys Sin (Shanghai) 2017;49:179-85. [PMID: 28039147 DOI: 10.1093/abbs/gmw123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
194 Tong YS, Tan J, Zhou XL, Song YQ, Song YJ. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer. J Transl Med. 2017;15:221. [PMID: 29089030 DOI: 10.7150/jca.2569110.1186/s12967-017-1326-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
195 Kayrak M, Erdoğan HI, Solak Y, Akilli H, Gül EE, Yildirim O, Erer M, Akilli NB, Bekci TT, Aribaş A, Yazici M. Prognostic value of neutrophil to lymphocyte ratio in patients with acute pulmonary embolism: a restrospective study. Heart Lung Circ 2014;23:56-62. [PMID: 23856365 DOI: 10.1016/j.hlc.2013.06.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 4.2] [Reference Citation Analysis]
196 Pian G, Li H, Piao Y. Clinical Significance of Inflammation Markers in Predicting the Severity of Acute Pancreatitis. Pancreas 2021;50:201-5. [PMID: 33565796 DOI: 10.1097/MPA.0000000000001749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
197 Yin Y, Wang J, Wang X, Gu L, Pei H, Kuai S, Zhang Y, Shang Z. Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis. Clinics (Sao Paulo) 2015;70:524-30. [PMID: 26222823 DOI: 10.6061/clinics/2015(07)10] [Cited by in Crossref: 69] [Cited by in F6Publishing: 81] [Article Influence: 9.9] [Reference Citation Analysis]
198 Furuta M, Yokota T, Tsushima T, Todaka A, Machida N, Hamauchi S, Yamazaki K, Fukutomi A, Kawai S, Kawabata T, Onozawa Y, Yasui H. Comparison of enteral nutrition with total parenteral nutrition for patients with locally advanced unresectable esophageal cancer harboring dysphagia in definitive chemoradiotherapy. Jpn J Clin Oncol 2019;49:910-8. [PMID: 31219161 DOI: 10.1093/jjco/hyz089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
199 Iwase T, Sangai T, Sakakibara M, Sakakibara J, Ishigami E, Hayama S, Nakagawa A, Masuda T, Tabe S, Nagashima T. An increased neutrophil-to-lymphocyte ratio predicts poorer survival following recurrence for patients with breast cancer. Mol Clin Oncol 2017;6:266-70. [PMID: 28357108 DOI: 10.3892/mco.2016.1101] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
200 Wang C, Cheng X, Jin L, Ren R, Wang S, Zheng A, Hao A, Zhou F, Zhang Y, Liu Q. Development and Validation of a Nomogram for Predicting Overall Survival to Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma. BioMed Research International 2022;2022:1-8. [DOI: 10.1155/2022/6455555] [Reference Citation Analysis]
201 Cananzi FCM, Dalgleish A, Mudan S. Surgical Management of Intraabdominal Metastases From Melanoma: Role of the Neutrophil to Lymphocyte Ratio as a Potential Prognostic Factor. World J Surg 2014;38:1542-50. [DOI: 10.1007/s00268-013-2418-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
202 Jomrich G, Paireder M, Kristo I, Baierl A, Ilhan-Mutlu A, Preusser M, Asari R, Schoppmann SF. High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma. Ann Surg 2021;273:532-41. [PMID: 31425286 DOI: 10.1097/SLA.0000000000003370] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 16.0] [Reference Citation Analysis]
203 Zhang LX, Wei ZJ, Xu AM, Zang JH. Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study. Int J Surg 2018;56:320-7. [PMID: 29969732 DOI: 10.1016/j.ijsu.2018.06.037] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
204 Omichi K, Cloyd JM, Yamashita S, Tzeng CD, Conrad C, Chun YS, Aloia TA, Vauthey JN. Neutrophil-to-lymphocyte ratio predicts prognosis after neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma. Surgery. 2017;162:752-765. [PMID: 28688518 DOI: 10.1016/j.surg.2017.05.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
205 Lin K, Jiang H, Zhuang SS, Qin YS, Qiu GD, She YQ, Zheng JT, Chen C, Fang L, Zhang SY. Long noncoding RNA LINC00261 induces chemosensitization to 5-fluorouracil by mediating methylation-dependent repression of DPYD in human esophageal cancer. FASEB J 2019;33:1972-88. [PMID: 30226808 DOI: 10.1096/fj.201800759R] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
206 Huang W, Wang S, Zhang H, Zhang B, Wang C. Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer. Cancer Biol Med 2018;15:88-96. [PMID: 29545972 DOI: 10.20892/j.issn.2095-3941.2017.0124] [Cited by in Crossref: 14] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
207 Yu Y, Wu H, Qiu J, Ke D, Wu Y, Lin M, Zheng Q, Zheng H, Wang Z, Li H, Liu L, Li J, Yao Q. The novel pretreatment immune prognostic index discriminates survival outcomes in locally advanced non-operative esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy: a 6-year retrospective study. Transl Oncol 2022;21:101430. [PMID: 35452997 DOI: 10.1016/j.tranon.2022.101430] [Reference Citation Analysis]
208 Ceylan C, Camtosun A, Doluoglu OG, Tasdemir S, Keles I, Aglamis E, Tatar CA. Emphasis of neutrophil-to-lymphocyte ratio in non-metastatic renal cell carcinoma. Urologia 2014;81:51-6. [PMID: 24474536 DOI: 10.5301/urologia.5000032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
209 Rossi L, Santoni M, Crabb SJ, Scarpi E, Burattini L, Chau C, Bianchi E, Savini A, Burgio SL, Conti A, Conteduca V, Cascinu S, De Giorgi U. High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer. Ann Surg Oncol 2015;22:1377-84. [PMID: 25234022 DOI: 10.1245/s10434-014-4097-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 7.1] [Reference Citation Analysis]
210 Tang H, Li B, Zhang A, Lu W, Xiang C, Dong J. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Colorectal Liver Metastasis: A Systematic Review and Meta-Analysis. PLoS One 2016;11:e0159447. [PMID: 27427969 DOI: 10.1371/journal.pone.0159447] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
211 Chen MF, Chen PT, Kuan FC, Chen WC. The Predictive Value of Pretreatment Neutrophil-To-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2019;26:190-9. [PMID: 30362062 DOI: 10.1245/s10434-018-6944-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
212 Wang Y, Fuentes HE, Attar BM, Jaiswal P, Demetria M. Evaluation of the prognostic value of neutrophil to lymphocyte ratio in patients with hypertriglyceridemia-induced acute pancreatitis. Pancreatology 2017;17:893-7. [PMID: 29030078 DOI: 10.1016/j.pan.2017.10.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
213 Sato H, Tsubosa Y, Kawano T. Correlation between the pretherapeutic neutrophil to lymphocyte ratio and the pathologic response to neoadjuvant chemotherapy in patients with advanced esophageal cancer. World J Surg. 2012;36:617-622. [PMID: 22223293 DOI: 10.1007/s00268-011-1411-1] [Cited by in Crossref: 97] [Cited by in F6Publishing: 100] [Article Influence: 9.7] [Reference Citation Analysis]
214 Mazzola A, Costantino A, Petta S, Bartolotta TV, Raineri M, Sacco R, Brancatelli G, Cammà C, Cabibbo G. Recurrence of hepatocellular carcinoma after liver transplantation: an update. Future Oncol 2015;11:2923-36. [PMID: 26414336 DOI: 10.2217/fon.15.239] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
215 Abu Omar Y, Randhawa T, Attar B, Agrawal R, Wang Y, Pichardo R, Majeed MB, Patel SA. Prognostic Value of Neutrophil-lymphocyte Ratio in Patients with Severe Alcoholic Hepatitis. Cureus. 2019;11:e6141. [PMID: 31886076 DOI: 10.7759/cureus.6141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
216 Gao F, Li X, Geng M, Ye X, Liu H, Liu Y, Wan G, Wang X. Pretreatment neutrophil-lymphocyte ratio: an independent predictor of survival in patients with hepatocellular carcinoma. Medicine (Baltimore). 2015;94:e639. [PMID: 25789957 DOI: 10.1097/md.0000000000000639] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
217 Dumitru CA, Moses K, Trellakis S, Lang S, Brandau S. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunol Immunother. 2012;61:1155-1167. [PMID: 22692756 DOI: 10.1007/s00262-012-1294-5] [Cited by in Crossref: 226] [Cited by in F6Publishing: 214] [Article Influence: 22.6] [Reference Citation Analysis]
218 Vatner RE, Formenti SC. Myeloid-derived cells in tumors: effects of radiation. Semin Radiat Oncol 2015;25:18-27. [PMID: 25481262 DOI: 10.1016/j.semradonc.2014.07.008] [Cited by in Crossref: 80] [Cited by in F6Publishing: 82] [Article Influence: 11.4] [Reference Citation Analysis]
219 Gulluoglu S, Tuysuz EC, Sahin M, Yaltirik CK, Kuskucu A, Ozkan F, Dalan AB, Sahin F, Ture U, Bayrak OF. The role of TNF-α in chordoma progression and inflammatory pathways. Cell Oncol (Dordr) 2019;42:663-77. [PMID: 31175552 DOI: 10.1007/s13402-019-00454-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
220 Wang Y, Dong X, Qu Z, Peng K, Sun X, Chen R. Correlation between peripheral blood neutrophil-lymphocyte ratio and CD34 expression in prostate cancer. BMC Cancer 2020;20:900. [PMID: 32962642 DOI: 10.1186/s12885-020-07382-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
221 Xu GW, Wu HR, Xiong R, Li CW, Liu CQ, Xu MQ, Xie MR. Value of the preoperative neutrophil-to-lymphocyte ratio as a prognostic factor for long-term survival in postoperative esophageal squamous cell carcinoma patients. Thorac Cancer 2018;9:1707-15. [PMID: 30311998 DOI: 10.1111/1759-7714.12885] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
222 Shijubou N, Sumi T, Yamada Y, Nakata H, Mori Y, Chiba H. Immunological and nutritional predictive factors in patients receiving pembrolizumab for the first-line treatment of non-small cell lung cancer. J Cancer Res Clin Oncol. [DOI: 10.1007/s00432-022-03941-2] [Reference Citation Analysis]
223 Suppan C, Bjelic-Radisic V, La Garde M, Groselj-Strele A, Eberhard K, Samonigg H, Loibner H, Dandachi N, Balic M. Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy. BMC Cancer 2015;15:1027. [PMID: 26715527 DOI: 10.1186/s12885-015-2005-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
224 Forget P, Dinant V, De Kock M. Is the Neutrophil-to-Lymphocyte Ratio more correlated than C-reactive protein with postoperative complications after major abdominal surgery? PeerJ 2015;3:e713. [PMID: 25653901 DOI: 10.7717/peerj.713] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
225 Zhang L, Su Y, Chen Z, Wei Z, Han W, Xu A. The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction. Medicine (Baltimore) 2017;96:e7647. [PMID: 28746229 DOI: 10.1097/MD.0000000000007647] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 3.2] [Reference Citation Analysis]
226 Chen S, Guo J, Feng C, Ke Z, Chen L, Pan Y. The preoperative platelet-lymphocyte ratio versus neutrophil-lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma? Ther Adv Med Oncol 2016;8:160-7. [PMID: 27239234 DOI: 10.1177/1758834016638019] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
227 Migita K, Matsumoto S, Wakatsuki K, Ito M, Kunishige T, Nakade H, Sho M. The Prognostic Significance of the Geriatric Nutritional Risk Index in Patients with Esophageal Squamous Cell Carcinoma. Nutr Cancer 2018;70:1237-45. [PMID: 30235009 DOI: 10.1080/01635581.2018.1512640] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
228 Wang F, Liu ZY, Xia YY, Zhou C, Shen XM, Li XL, Han SG, Zheng Y, Mao ZQ, Gong FR. Changes in neutrophil/lymphocyte and platelet/lymphocyte ratios after chemotherapy correlate with chemotherapy response and prediction of prognosis in patients with unresectable gastric cancer. Oncol Lett. 2015;10:3411-3418. [PMID: 26788143 DOI: 10.3892/ol.2015.3783] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
229 Abe T, Oshikiri T, Goto H, Kato T, Horikawa M, Sawada R, Harada H, Urakawa N, Hasegawa H, Kanaji S, Yamashita K, Matsuda T, Kakeji Y. Albumin-Derived NLR Score is a Novel Prognostic Marker for Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2021. [PMID: 34807322 DOI: 10.1245/s10434-021-11012-y] [Reference Citation Analysis]
230 Zhao QT, Yang Y, Xu S, Zhang XP, Wang HE, Zhang H, Wang ZK, Yuan Z, Duan GC. Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients. Onco Targets Ther 2015;8:2731-8. [PMID: 26491346 DOI: 10.2147/OTT.S90875] [Cited by in Crossref: 10] [Cited by in F6Publishing: 32] [Article Influence: 1.4] [Reference Citation Analysis]